ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 141 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $2,289,000 | +461.0% | 773,231 | +201.4% | 0.00% | – |
Q4 2018 | $408,000 | -80.5% | 256,529 | -54.8% | 0.00% | -100.0% |
Q3 2018 | $2,088,000 | +18.6% | 567,380 | -8.8% | 0.00% | 0.0% |
Q2 2018 | $1,760,000 | -40.4% | 621,860 | -21.9% | 0.00% | -50.0% |
Q1 2018 | $2,955,000 | +182.2% | 796,389 | +119.0% | 0.00% | +100.0% |
Q4 2017 | $1,047,000 | -27.4% | 363,571 | +13.2% | 0.00% | 0.0% |
Q3 2017 | $1,442,000 | -26.8% | 321,213 | -25.1% | 0.00% | 0.0% |
Q2 2017 | $1,969,000 | +14.7% | 428,933 | +5.2% | 0.00% | 0.0% |
Q1 2017 | $1,717,000 | +4.7% | 407,750 | +2.7% | 0.00% | 0.0% |
Q4 2016 | $1,640,000 | -59.5% | 397,192 | -20.5% | 0.00% | -66.7% |
Q3 2016 | $4,049,000 | +7.6% | 499,828 | +3.6% | 0.00% | 0.0% |
Q2 2016 | $3,764,000 | -7.1% | 482,512 | -8.1% | 0.00% | 0.0% |
Q1 2016 | $4,053,000 | -35.2% | 524,991 | -9.5% | 0.00% | -40.0% |
Q4 2015 | $6,257,000 | +89.4% | 579,919 | +21.3% | 0.01% | +66.7% |
Q3 2015 | $3,304,000 | -28.5% | 478,105 | -8.3% | 0.00% | 0.0% |
Q2 2015 | $4,620,000 | -2.4% | 521,428 | +8.6% | 0.00% | 0.0% |
Q1 2015 | $4,733,000 | -10.5% | 480,007 | +11.2% | 0.00% | -25.0% |
Q4 2014 | $5,289,000 | +17.3% | 431,781 | -4.4% | 0.00% | +33.3% |
Q3 2014 | $4,509,000 | +34.3% | 451,833 | +1.9% | 0.00% | +50.0% |
Q2 2014 | $3,357,000 | +151.3% | 443,495 | +9.2% | 0.00% | +100.0% |
Q1 2014 | $1,336,000 | -3.1% | 405,954 | -2.3% | 0.00% | 0.0% |
Q4 2013 | $1,379,000 | +18.3% | 415,484 | +7.6% | 0.00% | 0.0% |
Q3 2013 | $1,166,000 | -64.5% | 385,984 | -3.9% | 0.00% | -66.7% |
Q2 2013 | $3,284,000 | – | 401,503 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
Bellevue Group AG | 240,000 | $991,000 | 0.20% |